Validation of stopwatch measurements of erection duration against responses to the sexual encounter profile and international index of erectile Function in patients treated with a phosphodiesterase type 5 inhibitor

• Published in: Journal of sexual medicine Vol. 7; no. 3; p. 1147
• Main Authors: Shaw, James W, Reardon, Gregory, Sandor, David W, Rosen, Raymond C, Ferguson, David M
• Format: Journal Article
• Language: English
• Published: Netherlands 01.03.2010
• Subjects: Erectile Dysfunction - diagnosis; Erectile Dysfunction - drug therapy; Humans; Imidazoles - pharmacology; Imidazoles - therapeutic use; International Cooperation; Interpersonal Relations; Male; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors - pharmacology; Phosphodiesterase Inhibitors - therapeutic use; Piperazines - pharmacology; Piperazines - therapeutic use; Reference Values; Severity of Illness Index; Sexual Behavior; Sulfones - pharmacology; Sulfones - therapeutic use; Surveys and Questionnaires; Time Factors; Treatment Outcome; Triazines - pharmacology; Triazines - therapeutic use; Vardenafil Dihydrochloride

Although the Sexual Encounter Profile (SEP) and International Index of Erectile Function (IIEF) are frequently used to measure erectile dysfunction (ED) treatment outcomes, stopwatch-assessed duration of erection is a new, objective, and potentially useful endpoint of ED treatment effect. To assess...